Diclofenac Potassium ER 33% (WW) Pellets
Rraynex supplies Diclofenac Potassium ER 33% (WW) Pellets as extended-release pellets in the NSAID category, in a strength of 33%.
Product overview
Diclofenac is an NSAID used for pain and inflammation; extended-release forms reduce dosing frequency.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Formulation and release profile
Extended-release (ER) pellets prolong drug release over many hours so that a single daily or twice-daily dose maintains therapeutic levels.
Pharmaceutical applications
- Capsule filling of diclofenac potassium er 33% (ww) pellets for anti-inflammatory products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Diclofenac Potassium ER 33% (WW) Pellets
- Form
- extended-release Pellets
- Therapeutic category
- NSAID
- Strength
- 33%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Diclofenac Potassium ER 33% (WW) Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Diclofenac products from Rraynex
- Diclofenac Sodium — Pellets